MktsMarkets

Microbot Medical Inc.
NASDAQ: MBOTKey statistics
MBOT News
Stories mentioning MBOT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 105.00 | |||||||
| Cost of Goods Sold | 103.00 | |||||||
| Gross Profit | 2.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 1,293 | 1,542 | 1,171 | 2,111 | 1,459 | 1,984 | 2,060 | 1,417 |
| Sales General & Admin | 3,029 | 1,562 | ||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (4,320) | (4,138) | (3,861) | (3,723) | (3,021) | (3,430) | (3,300) | (2,511) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 316.00 | |||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (3,671) | (3,464) | (3,577) | (3,500) | (2,601) | (3,392) | (3,215) | (2,465) |
| Earnings Per Share (Basic) | (0.05) | (0.08) | (0.07) | (0.10) | (0.08) | (0.22) | (0.20) | (0.17) |
| Earnings Per Share (Diluted) | (0.05) | (0.08) | (0.07) | (0.10) | (0.08) | (0.22) | (0.20) | (0.17) |
| Weighted Average Shares Outstanding (Basic) | 67,158 | 45,790 | 48,095 | 36,488 | 31,086 | 15,645 | 16,471 | 14,847 |
| Weighted Average Shares Outstanding (Diluted) | 67,158 | 45,790 | 48,095 | 36,488 | 31,086 | 15,645 | 16,471 | 14,847 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MBOT
Microbot Medical Inc. (NASDAQ: MBOT) is a stock listed on the Nasdaq Stock Market under the ticker symbol MBOT. It last traded at $1.11 (Nov 6, 2026, 4:00 PM ET), up 3.7% on the day. That gives Microbot Medical a market capitalisation of $74.6M.
Over the past 52 weeks MBOT has traded between $0.9300 and $2.85.
Revenue for the quarter ended Mar 31, 2026 was $105.0K; a net loss of $3.7M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $105.0K | -$3.7M | -3496.2% |
| Dec 31, 2025 | — | -$3.5M | — |
| Sep 30, 2025 | — | -$3.6M | — |
| Jun 30, 2025 | — | -$3.5M | — |
From Microbot Medical’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…